$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
According to the Declaration of Helsinki, the study protocol was approved by the Ethics Institutional Review Board of the Third People's Hospital of Fujian Province (# 2020KS-5-1) and registered on the Chinese Clinical Trial Registry website on November 18, 2020 (identifier number ChiCTR2000041115). All participants provided written informed consent forms to participate in the study.
Participants
Here, 29 participants with knee OA and 21 participants with knee OA and increased CVD risk were recruited from Third People's Hospital of Fujian Province and neighboring communities. Inclusion criteria for the knee OA group were a clinical diagnosis according to the 2019 Diagnosis and Treatment of Osteoarthritis25, unilateral or bilateral Kellgren/Lawrence (K/L) grade ≥2, age 50-65 years, and low or no CVD risk as defined by Prediction for Atherosclerosis Cardiovascular Disease Risk in China (China-PAR)26. The knee OA with increased CVD risk group had the same age and knee OA symptoms as the knee OA group, but had medium or high CVD risk according to China-PAR. Participants in both groups were excluded if they had severe back pain, other lower extremity joint pain, rheumatoid arthritis, fractures, neurological system pathology, a medical history of CVD, and/or pulmonary disease.
Data collection
This study assessed the physical activity, pulmonary function, cardiopulmonary fitness, and muscle activity of subjects by administering the long-form International Physical Activity Questionnaire (IPAQ)27, pulmonary function test, cardiopulmonary exercise test, and surface electromyography (sEMG; Figure 1).
Physical activity assessment
The daily activity levels of participants were assessed using the Chinese version of the Long Form International Physical Activity Questionnaire (IPAQ; examining the validity and reliability of the Chinese version of the International Physical Activity Questionnaire, long form (IPAQ-LC)27, administered in an interview format. This study collected and analyzed data on physical activity during leisure time, domestic and gardening (yard), work-related, and transport-related activities in the past month using the IPAQ. The scores were reported in metabolic equivalent (MET)-min/week, which were calculated by multiplying the number of min per week of activities performed by their respective MET values. Finally, the scores were categorized into walking, moderate, vigorous, and total physical activity. Cases were excluded from the analysis if responses regarding time or frequency were reported as don't know, refused to answer, or were missing.
Pulmonary function test
Prior to the test, we conducted an instrument calibration. The calibration included environmental preparation, volume calibration, and flow/volume sensor calibration. Participants were instructed to abstain from food for 2 h before the experiment.
A nose clip was applied to ensure exclusive oral airflow. The subject then sealed their lips around the mouthpiece to prevent leakage. Strong verbal encouragement was provided throughout the maneuver to maximize effort. Subjects were coached by experienced respiratory therapists using American Thoracic Society guidelines on the Pulmonary Function Test System (230 V, 50/60 Hz, 508 VA, IP20). Spirometry included measurements of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC), and maximal voluntary ventilation (MVV). Each subject generated at least three technically acceptable maneuvers. A sharp start of exhalation is required for FVC and FEV1 measurement, and exhalation must last at least 6 s, with less than a 5% variation between repeat maneuvers. During the MVV test, the subject is instructed to perform the deepest and fastest possible breathing maneuvers for 12 s. Best test results were chosen by the technician as those having the highest FVC, FEV1, MVV values, and the best flow volume curves.
Cardiopulmonary exercise test
After performing the pulmonary function test for at least 5 min, a 12-lead electrocardiograph (ECG), an automated cuff, a breathing mask, and an oxygen photometer were attached to monitor heart rate, electrocardiograph, blood pressure, gas exchange, and oxygen saturation.
Participants underwent an incremental maximal CPET utilizing the treadmill and the modified Bruce protocol (see Table 1). Baseline cardiopulmonary values were assessed during a 3 min rest period while seated in the chair; thereafter, a 3 min warm-up was performed on a treadmill at a velocity of 2.7 km/h with zero incline. After the warm-up, exercise intensity was increased every 3 min according to the Modified Bruce protocol, with sequential stages as follows: 2.7 km/h at 0% grade, 2.7 km/h at 5% grade, 2.7 km/h at 10% grade, 4.0 km/h at 12% grade, 5.4 km/h at 14% grade, and 6.7 km/h at 16% grade, aimed at reaching a maximal effort. Holding on to the treadmill handrails was discouraged; however, some patients required the handrails to maintain their balance.
The entire test was monitored by professional cardiologists. During the rest phase, blood pressure (BP) was measured once, and continuously monitored with 12-lead ECG, heart rate (HR), and oxyhemoglobin saturation. During the exercise phase, ECG, HR, and oxyhemoglobin saturation were continuously monitored, and ambulatory BP, symptoms, and fatigue level were monitored every 3 min. Exercise was stopped when participants reached maximum HR, or oxygen uptake did not rise while exercise load increased, or the perceived score (ratings of perceived exertion (RPE) of the Borg (6-20)28) was greater than 17. During recovery, ECG, HR, and oxyhemoglobin saturation were continuously monitored, and BP was measured every 2 min. The test was stopped prematurely for symptoms like significant breathlessness, chest constriction, or dizziness, progressive ventricular ectopy > 3 beats, new atrial fibrillation, sustained decrease in systolic blood pressure > 20 mmHg from the previous stage, or depression of more than 5 mm ST segment.
Testing personnel were proficient in emergency procedures, with essential equipment (including a defibrillator, oxygen, and breathing masks) and medications (e.g., epinephrine, atropine, lidocaine, nitroglycerin, and glucose) available on-site. In any critical event, the test was terminated immediately. Management involved maintaining patent airways, administering oxygen, and establishing intravenous access. Subsequent resuscitation and pharmacological interventions adhered to Advanced Cardiac Life Support (ACLS) protocols, concurrent with activation of the emergency response team for patient transfer.
Breath-by-breath measurements were taken of oxygen uptake (VO2), carbon dioxide output (VCO2), minute ventilation (VE), partial pressure of end-tidal oxygen (PETO2), and carbon dioxide (PETCO2). Heart rate (HR) was recorded at 1 s intervals. The highest value within the last 60 s of exercise was defined as VO2peak, VCO2peak, VEpeak, HRpeak, and the peak of oxygen pulse (VO2 / HRpeak), PETO2peak, PETCO2peak. The anaerobic threshold (AT) was defined by the modified V-slope approach29. The heart rate reserve (HRR) was defined as 220 - a - HRMax during the exercise phase, in which stands a for age and HRMax stands for the maximum heart rate.
sEMG signals of the lower limbs during stair climbing
Prior to electrode placement, participants wore uniformly procured Anta sports shoes and performed five stair-negotiation trials. These trials were executed at a self-selected daily walking speed and without the use of a handrail. Each step was fixed at a width of 100 cm, a height of 20 cm, and a depth of 30 cm. The speeds of stair ascent and descent were recorded by infrared timing systems positioned at both the first and the top steps. The mean ±10% of speeds across the five stair negotiation trials was defined as the normal speed. Official trials with speeds that deviated from the normal speed were excluded from subsequent analysis.
The skin over the target muscles is then prepared by shaving, light abrasion with fine-grit sandpaper, and cleansing with 70% alcohol to reduce impedance and ensure optimal contact. After skin preparation, surface EMG electrodes were placed on the target muscle bellies. The study used a wireless sEMG system to measure muscle activities during the stance phase at a sampling frequency of 2000 Hz. Adhesive pre-gelled Ag/AgCl electrodes (10 mm fixed inter-electrode distance) were placed bilaterally on the tibialis anterior (TA), medial head of gastrocnemius muscle (MG), biceps femoris (BF), rectus femoris (RF), vastus medialis (VM), vastus lateralis (VL), gluteus maximus (GMAX), and gluteus medius (GMED) muscles (see Table 2). Participants then performed maximum voluntary isometric contraction (MVIC) for each investigated muscle, which was used in amplitude normalization tests (see Table 3). Participants were instructed to perform the test action with maximal effort for 4-5 s. Strong verbal encouragement was provided throughout each trial. This procedure was repeated 3x with a 2 min rest interval between trials to prevent fatigue. After the MVIC test, the participants were asked to perform five successful trials of stair ascent and descent at normal speed. The sEMG data during the stance phase were selected in the third and fourth steps of the custom eight-step laboratory staircase.
The stance phase sEMG signals of stair tasks and MVIC were processed in the Visual3D software. The raw data were first band-pass filtered (20-450 Hz), full-wave rectified, smoothed with a 50 ms root mean square (RMS) window, and finally low-pass filtered at 6 Hz to create a linear envelope. The stance phase was identified from the vertical ground reaction force (>10 N threshold). The linear envelope for each stance phase was time-normalized to 101 points and amplitude-normalized to the corresponding maximum value of MVIC. Finally, the RMS of each normalized sEMG data during the stance phase was calculated to reflect the magnitude of muscle activity. The analysis focused on the more symptomatic knee in subjects of the two groups. If the symptoms of both knees were similar, data for the technology-dominant limb were selected.
Statistical analysis
All statistical analyses were conducted using SPSS Statistics 25.0. All variables were presented as mean ±standard deviation. The Shapiro-Wilk test was used to test the normality of all quantitative variables. The normally distributed variables difference of two independent samples in demographics, cardiopulmonary function parameters, and RMS were assessed using independent-samples t-tests; the skewed distribution variables difference was assessed using the Kruskal-Wallis test. The IPAQ scores and K/L grade differences were assessed using the Kruskal-Wallis test. Chi-square test was used to compare the difference in gender. Correlations between different and powerful parameters of cardiopulmonary function (peak of oxygen uptake (VO2peak), maximal voluntary ventilation (MVV), and RMS (biceps femoris (BF)) in knee OA with CVD risk group were detected using Spearman correlations.